Dermata Therapeutics Inc
DRMA7.060USD
+0.610+9.46%
收盘 08/04, 16:00（美东）报价延迟15分钟
7.060USD+7.060盘后交易 (美东)
42.59M总市值
亏损市盈率 TTM
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
营业费用
-26.96%2.34M
44.17%3.20M
78.02%3.23M
66.46%2.88M
40.65%3.20M
29.69%2.22M
-25.92%1.81M
-36.55%1.73M
-18.25%2.28M
-32.95%1.71M
42.86%2.45M
105.31%2.73M
23.18%2.79M
419.48%2.55M
217.05%1.71M
67.76%1.33M
67.72%2.26M
--491.43K
--540.06K
--792.79K
--1.35M
研发费用
-19.97%1.28M
93.13%2.19M
165.94%2.40M
139.48%2.01M
34.22%1.60M
27.65%1.14M
-41.87%902.98K
-47.97%838.93K
-25.27%1.19M
-20.01%889.36K
94.22%1.55M
85.95%1.61M
134.48%1.60M
872.69%1.11M
563.90%799.78K
110.51%867.20K
-29.19%680.59K
--114.30K
--120.47K
--411.95K
--961.10K
折旧摊销及损耗
--0.00
----
----
--0.00
--0.00
----
----
----
--0.00
----
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
-100.00%0.00
--0.00
--0.00
--0.00
--322.00
营业利润
26.96%-2.34M
-44.17%-3.20M
-78.02%-3.23M
-66.46%-2.88M
-40.65%-3.20M
-29.69%-2.22M
25.92%-1.81M
36.55%-1.73M
18.25%-2.28M
32.95%-1.71M
-42.86%-2.45M
-105.31%-2.73M
-23.18%-2.79M
-419.48%-2.55M
-217.05%-1.71M
-67.76%-1.33M
-67.72%-2.26M
---491.43K
---540.06K
---792.79K
---1.35M
净非营业利息收入（费用）
利息费用
----
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
-98.86%651.00
-93.68%1.82K
-40.58%43.13K
--38.48K
--57.33K
--28.86K
--72.60K
特殊收入（费用）
----
----
----
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
----
----
----
--133.59K
----
----
----
税前利润
26.50%-2.30M
-47.66%-3.15M
-84.57%-3.17M
-66.28%-2.83M
-39.91%-3.13M
-27.81%-2.13M
29.09%-1.72M
37.69%-1.70M
19.60%-2.24M
34.60%-1.67M
-41.55%-2.42M
-105.03%-2.73M
-20.88%-2.79M
-544.15%-2.55M
-186.73%-1.71M
-62.09%-1.33M
-62.18%-2.30M
---396.31K
---597.39K
---821.65K
---1.42M
除税后利润
26.50%-2.30M
-47.66%-3.15M
-84.57%-3.17M
-66.28%-2.83M
-39.91%-3.13M
-27.81%-2.13M
29.09%-1.72M
37.69%-1.70M
19.60%-2.24M
34.60%-1.67M
-41.55%-2.42M
-105.03%-2.73M
-20.88%-2.79M
-544.15%-2.55M
-186.73%-1.71M
-62.09%-1.33M
-62.18%-2.30M
---396.31K
---597.39K
---821.65K
---1.42M
持续经营利润
26.50%-2.30M
-47.66%-3.15M
-84.57%-3.17M
-66.28%-2.83M
-39.91%-3.13M
-27.81%-2.13M
29.09%-1.72M
37.69%-1.70M
19.60%-2.24M
34.60%-1.67M
-41.55%-2.42M
-105.03%-2.73M
-20.88%-2.79M
-544.15%-2.55M
-186.73%-1.71M
-62.09%-1.33M
-62.18%-2.30M
---396.31K
---597.39K
---821.65K
---1.42M
归属于母公司的净利润
26.50%-2.30M
-47.66%-3.15M
-84.57%-3.17M
-66.28%-2.83M
-39.91%-3.13M
-27.81%-2.13M
29.09%-1.72M
37.69%-1.70M
19.60%-2.24M
67.36%-1.67M
43.29%-2.42M
-105.03%-2.73M
-20.88%-2.79M
-1190.67%-5.12M
-615.63%-4.28M
-62.09%-1.33M
-62.18%-2.30M
---396.31K
---597.39K
---821.65K
---1.42M
优先股派息
----
----
----
----
----
----
----
----
----
----
----
----
----
--2.56M
--2.56M
----
----
----
----
----
----
归属于普通股东的净利润
26.50%-2.30M
-47.66%-3.15M
-84.57%-3.17M
-66.28%-2.83M
-39.91%-3.13M
-27.81%-2.13M
29.09%-1.72M
37.69%-1.70M
19.60%-2.24M
67.36%-1.67M
43.29%-2.42M
-105.03%-2.73M
-20.88%-2.79M
-1190.67%-5.12M
-615.63%-4.28M
-62.09%-1.33M
-62.18%-2.30M
---396.31K
---597.39K
---821.65K
---1.42M
基本每股收益
93.67%-0.45
69.15%-2.06
74.76%-2.04
55.68%-4.18
79.29%-7.06
79.44%-6.68
82.94%-8.09
83.88%-9.43
57.42%-34.08
77.96%-32.48
76.99%-47.40
-52.53%-58.54
-20.53%-80.06
-1190.79%-147.40
-1096.72%-206.02
-62.10%-38.38
-62.18%-66.42
---11.42
---17.22
---23.68
---40.95
稀释每股收益
93.67%-0.45
69.15%-2.06
74.76%-2.04
55.68%-4.18
79.29%-7.06
79.44%-6.68
82.94%-8.09
83.88%-9.43
57.42%-34.08
77.96%-32.48
76.99%-47.40
-52.53%-58.54
-20.53%-80.06
-1190.79%-147.40
-1096.72%-206.02
-62.10%-38.38
-62.18%-66.42
---11.42
---17.22
---23.68
---40.95
每股派息
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
货币单位
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
审计意见
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
